|
Lacutoclax+Rocbrutinib Clinical Trials
1 actively recruiting trial
Pipeline
Phase 1/2: 1
Top Sponsors
- Guangzhou Lupeng Pharmaceutical Company LTD.1
Indications
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)1
- Waldenström Macroglobulinemia (WM)1
- Follicular Lymphoma ( FL)1
- Mantle Cell Lymphoma (MCL)1
- Diffuse Large B-cell Lymphoma(DLBCL)1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.